Private Equity
Tryton Medical Inc., a Durham, N.C.-based developer of stents designed to treat bifurcation lesions, closed a $20 million Series D round of financing. Current investors PTV Sciences, RiverVest Venture Partners and Spray Venture Partners participated in the round. The financing was lead by Arnerich Massena. Arnerich Massena’s Russell J. Rottiers joined Tryton as a director.
3 min read · 14 September 2010
StorSimple named Ian Howells as chief marketing officer. Howells will be responsible for the developer of application-optimized hybrid storage solution’s marketing strategy and operational activities worldwide. He previously worked for Alfresco, where he was core part of the team that built it from a startup. StorSimple isfunded by Ignition Partners, Index Ventures, Mayfield Fund and Redpoint Ventures.
2 min read · 14 September 2010
Matrix hired Vincenzo Narciso as a partner in its private funds group, where he will focus on both originating and raising capital for international private equity and venture capital funds. Prior to joining Matrix, Narciso was head of UBP Private Equity activities.
2 min read · 09 September 2010
General Atlantic LLC named Gary M. Reiner as a special advisor. Reiner will also serve as a director of, and offer deep operational expertise to, the firm’s portfolio companies. He previously served as General Electric Co.’s chief information officer.
2 min read · 08 September 2010
Sofinnova Ventures named Garheng Kong a general partner. Kong will invest in biopharmaceutical companies from the firm's SVP VII fund. Kong was previously general partner at Intersouth Partners, where he worked for 10 years.
3 min read · 08 September 2010
Industry Ventures LLC named Victor Hwang as managing director. It also promoted Will Quist to managing director and Dan Stevens to associate. Hwang has worked for the San Francisco-based firm as a venture partner for more than a year.
4 min read · 08 September 2010
Nanobiotix, a Paris-based nanomedecine company that is developing cancer treatments, named Laurent Condomine to its non-executive board. Condomine has been vice president of business development at AstraZeneca. Nanobiotix has been primarily funded by European venture capital firms: Amorcage Rhone-Alpes, Cap Decisif, CIC Vizille, Masseran Gestion-CGE, Matignon Technologies and OTC Asset Management.
3 min read · 07 September 2010
Stentys named Stanislas Piot chief financial officer. Piot held a similar post at Ipsogen, which develops molecular diagnostic tools. Paris-based Stentys develops stents to treat heart attack patients. It is backed by Credit Agricole Private Equity, Scottish Equity Partners and Sofinnova Partners.
2 min read · 02 September 2010
Index Ventures said Kevin Johnson expanded his relationship with the firm. He was named a partner in the life sciences team and will focus on seeking new assets in the biologics area. He served as a venture advisor since 2004.
3 min read · 02 September 2010
Recurve named Andy Leventhal its chief executive officer. Leventhal is a 25-year software entrepreneur, who has e worked at EMC, Imperva, Red Hat and VeriSign. He replaces Pratap Mukherjee, who plans to pursue other opportunities.Recurve is a San Francisco-based provider of software and services for the home performance industry is backed by Lowe’s Cos., RockPort Capital Partners and Shasta Ventures.
4 min read · 02 September 2010
